HC Deb 05 November 2002 vol 392 c256W
John Mann

To ask the Secretary of State for Health what information he intends to provide to patients regarding the safe(a) transport, (b) storage and (c) use of biological drugs. [78489]

Ms Blears

information regarding the transport, storage and use of biological drugs is specifically provided on the product label and, in more detail, in the patient information leaflet (PIL). The PIL is supplied with the packaged product. Information and advice on transport, storage and handling of each medicinal product is based upon the scientific data, including the stability of the drug in the final packaging, which is evaluated as part of the marketing authorisation application.

Forward to